Mind Medicine (MindMed) Statistics

Total Valuation

MNMD has a market cap or net worth of $472.99 million. The enterprise value is $254.11 million.

Market Cap	472.99M
Enterprise Value	254.11M

Important Dates

The next estimated earnings date is Monday, November 4, 2024, after market close.

Earnings Date	Nov 4, 2024
Ex-Dividend Date	n/a

Share Statistics

MNMD has 73.33 million shares outstanding. The number of shares has increased by 39.00% in one year.

Shares Outstanding	73.33M
Shares Change (YoY)	+39.00%
Shares Change (QoQ)	+57.34%
Owned by Insiders (%)	1.01%
Owned by Institutions (%)	39.50%
Float	59.34M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.30
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.92, with a Debt / Equity ratio of 0.12.

Current Ratio	5.92
Quick Ratio	5.81
Debt / Equity	0.12
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-121.13

Financial Efficiency

Return on equity (ROE) is -66.26% and return on invested capital (ROIC) is -34.03%.

Return on Equity (ROE)	-66.26%
Return on Assets (ROA)	-27.57%
Return on Capital (ROIC)	-34.03%
Revenue Per Employee	n/a
Profits Per Employee	-$1.79M
Employee Count	57
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +161.13% in the last 52 weeks. The beta is 2.36, so MNMD's price volatility has been higher than the market average.

Beta (5Y)	2.36
52-Week Price Change	+161.13%
50-Day Moving Average	5.99
200-Day Moving Average	7.16
Relative Strength Index (RSI)	57.07
Average Volume (20 Days)	621,703

Short Selling Information

The latest short interest is 10.21 million, so 13.93% of the outstanding shares have been sold short.

Short Interest	10.21M
Short Previous Month	10.36M
Short % of Shares Out	13.93%
Short % of Float	17.21%
Short Ratio (days to cover)	14.93

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-90.48M
Pretax Income	-125.32M
Net Income	-102.04M
EBITDA	n/a
EBIT	-90.48M
Earnings Per Share (EPS)	-$2.05

Full Income Statement

Balance Sheet

The company has $243.13 million in cash and $24.25 million in debt, giving a net cash position of $218.88 million or $2.98 per share.

Cash & Cash Equivalents	243.13M
Total Debt	24.25M
Net Cash	218.88M
Net Cash Per Share	$2.98
Equity (Book Value)	202.05M
Book Value Per Share	2.80
Working Capital	205.85M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-73.78M
Capital Expenditures	n/a
Free Cash Flow	-73.78M
FCF Per Share	-$1.01

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MNMD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-39.00%
Shareholder Yield	-39.00%
Earnings Yield	-21.57%
FCF Yield	-15.60%

Analyst Forecast

The average price target for MNMD is $28.75, which is 345.74% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$28.75
Price Target Difference	345.74%
Analyst Consensus	Strong Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on August 29, 2022. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	Aug 29, 2022
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2